Valneva SE VALN recently applied for a label extension to the FDA to potentially extend the use of its chikungunya vaccine, IXCHIQ. Currently approved for adults, the vaccine may soon be accessible to ...
Valneva submits label extension application to US FDA for chikungunya vaccine, IXCHIQ: Saint Herblain, France Thursday, November 28, 2024, 16:00 Hrs [IST] Valneva SE, a specialty ...